#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acromegaly Malignant central nervous system neoplasm Thyroid cancer metastatic Immunodeficiency common variable Malignant melanoma Prolymphocytic leukaemia Ependymoma Fungal infection Osteosarcoma Urea cycle disorder Meningitis meningococcal Breast cancer Inborn error of metabolism Non-renal cell carcinoma of kidney Glomerulonephritis chronic More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Basic Information Undifferentiated sarcoma – Treatment Medulloblastoma – Basic Information Hereditary motor and sensory neuropathy – Treatment Cytokine release syndrome – Basic Information Pemphigoid – Diagnostics Proteus syndrome Idiopathic pulmonary fibrosis – Diagnostics Chondrosarcoma metastatic – Diagnostics Shprintzen-Goldberg syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rondaptivon Pegol Human Normal Immunoglobulin Treprostinil Phenazone RP3 Vitamin A Bp Human Coagulation Factor Viii Gadoteridol Rizolipase Lamotrigine Alx148 SODIUM FUSIDATE Dexamethasone Isonicotinate Namodenoson Prednisone Alectinib Hydrochloride Codeine Phosphate Methyl Aminolevulinate Morf-057 Cyclophosphamide Monohydrate More therapies…

    Learn about Your Condition

    Conjunctivitis Thromboembolectomy Dyslipidaemia Cough Transplant rejection Trisomy 21 Syphilis Renal injury Tertiary adrenal insufficiency Pancreatitis relapsing Alport's syndrome Myocarditis Breast cancer in situ Multiple system atrophy Vulvovaginal pruritus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

    Not recruiting

    2 1
    Investigated Drugs:
    • Frexalimab
    Greece Hungary Italy Spain

  • Study on the Safety and Effects of PBF-999 for Patients with Prader-Willi Syndrome

    Not recruiting

    2 1
    Investigated Drugs:
    • Pbf-999
    Spain

  • Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1
    Investigated Diseases:
    • Ankylosing spondylitis
    • Axial spondyloarthritis
    Investigated Drugs:
    • Abt-494
    Belgium Bulgaria Czechia France Germany Hungary +3

  • Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Enzalutamide
    • Pembrolizumab
    Austria Bulgaria Czechia France Germany Hungary +5

  • Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute hepatic failure
    • Hepatic cirrhosis
    • Inborn error of metabolism
    Investigated Drugs:
    • Hhalpc
    Belgium Bulgaria France Poland Spain

  • Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Prostate cancer
    Investigated Drugs:
    • Vobramitamab Duocarmazine
    • Prednisone
    Belgium Czechia France Germany Italy Poland +1

  • Study on the Safety and Effectiveness of Guanfacine Hydrochloride and Atomoxetine Hydrochloride for Children and Adolescents with ADHD Aged 6 to 17 Years

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Atomoxetine Hydrochloride
    • Guanfacine
    Belgium Germany The Netherlands Spain Sweden

  • Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9

  • Study on Darolutamide and Androgen Deprivation Therapy for Men with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Darolutamide
    Latvia Lithuania Spain

  • Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia Denmark Finland France +13
Previous Page
1 … 24 25 26 27 28 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!